Noselab

A window to the brain. Noselab is a pioneering force in diagnostic breakthrough technology, specializing in the early detection and management of brain diseases. The company is developing a groundbreaking, non-invasive, and scalable biomarker platform that enables the detection, measurement, and clinical validation of brain-derived molecular biomarkers in nasal secretion – powered by AI-driven patient profiling and stratification for precision medicine. By leveraging the brain-nose interface (BNI) as a structural and functional gateway to the central nervous system, and supported by multiple independent studies confirming the presence of CNS biomarkers in nasal samples, Noselab is pioneering a novel diagnostic approach in neuroscience. As a member of the Bavarian Biotech cluster, Noselab collaborates with leading experts and institutions to drive innovation and foster collaboration in biomedical research and development. Our vision: Revolutionizing the understanding, diagnosis and treatment of diseases leveraging the brain-nose interface. Our mission: Establish Noselab as a platform for brain-derived biomarkers in nasal secretion. Interested to join our team? Contact us.

• Employees 21
• Founded 2020